nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Temozolomide—melanoma	0.178	0.576	CbGbCtD
Etonogestrel—CYP3A4—Vemurafenib—melanoma	0.0973	0.316	CbGbCtD
Etonogestrel—CYP3A4—Docetaxel—melanoma	0.0334	0.108	CbGbCtD
Etonogestrel—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00176	0.00405	CcSEcCtD
Etonogestrel—Abdominal distension—Temozolomide—melanoma	0.00175	0.00402	CcSEcCtD
Etonogestrel—Fluid retention—Docetaxel—melanoma	0.00175	0.00402	CcSEcCtD
Etonogestrel—Decreased appetite—Vemurafenib—melanoma	0.00168	0.00386	CcSEcCtD
Etonogestrel—Bronchitis—Temozolomide—melanoma	0.00167	0.00384	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Vemurafenib—melanoma	0.00167	0.00384	CcSEcCtD
Etonogestrel—Fatigue—Vemurafenib—melanoma	0.00167	0.00383	CcSEcCtD
Etonogestrel—Neoplasm—Docetaxel—melanoma	0.00167	0.00383	CcSEcCtD
Etonogestrel—Haemoglobin—Bleomycin—melanoma	0.00166	0.00381	CcSEcCtD
Etonogestrel—Constipation—Vemurafenib—melanoma	0.00165	0.0038	CcSEcCtD
Etonogestrel—Haemorrhage—Bleomycin—melanoma	0.00165	0.00379	CcSEcCtD
Etonogestrel—Hypoaesthesia—Bleomycin—melanoma	0.00164	0.00377	CcSEcCtD
Etonogestrel—Dysuria—Temozolomide—melanoma	0.00163	0.00373	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Temozolomide—melanoma	0.00162	0.00371	CcSEcCtD
Etonogestrel—Pollakiuria—Temozolomide—melanoma	0.00161	0.00369	CcSEcCtD
Etonogestrel—Depression—Carmustine—melanoma	0.0016	0.00367	CcSEcCtD
Etonogestrel—Weight increased—Temozolomide—melanoma	0.00158	0.00363	CcSEcCtD
Etonogestrel—Weight decreased—Temozolomide—melanoma	0.00157	0.00361	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Carmustine—melanoma	0.00157	0.00361	CcSEcCtD
Etonogestrel—Urinary tract infection—Carmustine—melanoma	0.00156	0.00358	CcSEcCtD
Etonogestrel—Infestation NOS—Temozolomide—melanoma	0.00155	0.00356	CcSEcCtD
Etonogestrel—Infestation—Temozolomide—melanoma	0.00155	0.00356	CcSEcCtD
Etonogestrel—Depression—Temozolomide—melanoma	0.00155	0.00355	CcSEcCtD
Etonogestrel—Body temperature increased—Vemurafenib—melanoma	0.00153	0.00351	CcSEcCtD
Etonogestrel—Pharyngitis—Dactinomycin—melanoma	0.00153	0.00351	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Temozolomide—melanoma	0.00152	0.00349	CcSEcCtD
Etonogestrel—Swelling—Docetaxel—melanoma	0.00152	0.00348	CcSEcCtD
Etonogestrel—Urinary tract infection—Temozolomide—melanoma	0.00151	0.00346	CcSEcCtD
Etonogestrel—Alopecia—Bleomycin—melanoma	0.00146	0.00335	CcSEcCtD
Etonogestrel—Sinusitis—Temozolomide—melanoma	0.00145	0.00334	CcSEcCtD
Etonogestrel—Haemoglobin—Carmustine—melanoma	0.00145	0.00332	CcSEcCtD
Etonogestrel—Haemorrhage—Carmustine—melanoma	0.00144	0.00331	CcSEcCtD
Etonogestrel—Erythema—Bleomycin—melanoma	0.00144	0.0033	CcSEcCtD
Etonogestrel—Hypoaesthesia—Carmustine—melanoma	0.00143	0.00329	CcSEcCtD
Etonogestrel—Hot flush—Docetaxel—melanoma	0.00143	0.00328	CcSEcCtD
Etonogestrel—Hypersensitivity—Vemurafenib—melanoma	0.00143	0.00327	CcSEcCtD
Etonogestrel—Menopausal symptoms—Docetaxel—melanoma	0.00142	0.00326	CcSEcCtD
Etonogestrel—Connective tissue disorder—Carmustine—melanoma	0.00142	0.00325	CcSEcCtD
Etonogestrel—Visual disturbance—Docetaxel—melanoma	0.00141	0.00324	CcSEcCtD
Etonogestrel—Haemoglobin—Temozolomide—melanoma	0.0014	0.00321	CcSEcCtD
Etonogestrel—Haemorrhage—Temozolomide—melanoma	0.00139	0.0032	CcSEcCtD
Etonogestrel—Asthenia—Vemurafenib—melanoma	0.00139	0.00319	CcSEcCtD
Etonogestrel—Visual impairment—Carmustine—melanoma	0.00139	0.00319	CcSEcCtD
Etonogestrel—Hypoaesthesia—Temozolomide—melanoma	0.00138	0.00318	CcSEcCtD
Etonogestrel—Pharyngitis—Temozolomide—melanoma	0.00138	0.00317	CcSEcCtD
Etonogestrel—Urinary tract disorder—Temozolomide—melanoma	0.00137	0.00316	CcSEcCtD
Etonogestrel—Pruritus—Vemurafenib—melanoma	0.00137	0.00314	CcSEcCtD
Etonogestrel—Connective tissue disorder—Temozolomide—melanoma	0.00137	0.00314	CcSEcCtD
Etonogestrel—Urethral disorder—Temozolomide—melanoma	0.00136	0.00313	CcSEcCtD
Etonogestrel—Alopecia—Dactinomycin—melanoma	0.00136	0.00312	CcSEcCtD
Etonogestrel—Eye disorder—Carmustine—melanoma	0.00135	0.00309	CcSEcCtD
Etonogestrel—Visual impairment—Temozolomide—melanoma	0.00134	0.00308	CcSEcCtD
Etonogestrel—Erythema—Dactinomycin—melanoma	0.00134	0.00308	CcSEcCtD
Etonogestrel—Pain in extremity—Docetaxel—melanoma	0.00134	0.00307	CcSEcCtD
Etonogestrel—Ill-defined disorder—Bleomycin—melanoma	0.00133	0.00306	CcSEcCtD
Etonogestrel—Diarrhoea—Vemurafenib—melanoma	0.00132	0.00304	CcSEcCtD
Etonogestrel—Migraine—Docetaxel—melanoma	0.00132	0.00302	CcSEcCtD
Etonogestrel—Eye disorder—Temozolomide—melanoma	0.0013	0.00299	CcSEcCtD
Etonogestrel—Malaise—Bleomycin—melanoma	0.0013	0.00297	CcSEcCtD
Etonogestrel—Dizziness—Vemurafenib—melanoma	0.00128	0.00294	CcSEcCtD
Etonogestrel—Alopecia—Carmustine—melanoma	0.00127	0.00292	CcSEcCtD
Etonogestrel—Angiopathy—Temozolomide—melanoma	0.00126	0.0029	CcSEcCtD
Etonogestrel—Mental disorder—Carmustine—melanoma	0.00126	0.0029	CcSEcCtD
Etonogestrel—Immune system disorder—Temozolomide—melanoma	0.00126	0.00289	CcSEcCtD
Etonogestrel—Erythema—Carmustine—melanoma	0.00125	0.00288	CcSEcCtD
Etonogestrel—Malnutrition—Carmustine—melanoma	0.00125	0.00288	CcSEcCtD
Etonogestrel—Cough—Bleomycin—melanoma	0.00125	0.00288	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dactinomycin—melanoma	0.00124	0.00285	CcSEcCtD
Etonogestrel—Vomiting—Vemurafenib—melanoma	0.00123	0.00282	CcSEcCtD
Etonogestrel—Alopecia—Temozolomide—melanoma	0.00123	0.00282	CcSEcCtD
Etonogestrel—Myalgia—Bleomycin—melanoma	0.00122	0.00281	CcSEcCtD
Etonogestrel—Rash—Vemurafenib—melanoma	0.00122	0.0028	CcSEcCtD
Etonogestrel—Mental disorder—Temozolomide—melanoma	0.00122	0.0028	CcSEcCtD
Etonogestrel—Dermatitis—Vemurafenib—melanoma	0.00122	0.0028	CcSEcCtD
Etonogestrel—Back pain—Carmustine—melanoma	0.00121	0.00278	CcSEcCtD
Etonogestrel—Headache—Vemurafenib—melanoma	0.00121	0.00278	CcSEcCtD
Etonogestrel—Erythema—Temozolomide—melanoma	0.00121	0.00278	CcSEcCtD
Etonogestrel—Malnutrition—Temozolomide—melanoma	0.00121	0.00278	CcSEcCtD
Etonogestrel—Breast disorder—Docetaxel—melanoma	0.00121	0.00278	CcSEcCtD
Etonogestrel—Discomfort—Bleomycin—melanoma	0.00121	0.00277	CcSEcCtD
Etonogestrel—Malaise—Dactinomycin—melanoma	0.00121	0.00277	CcSEcCtD
Etonogestrel—Cramp muscle—Docetaxel—melanoma	0.0012	0.00277	CcSEcCtD
Etonogestrel—Anaphylactic shock—Bleomycin—melanoma	0.00117	0.00269	CcSEcCtD
Etonogestrel—Oedema—Bleomycin—melanoma	0.00117	0.00269	CcSEcCtD
Etonogestrel—Back pain—Temozolomide—melanoma	0.00117	0.00269	CcSEcCtD
Etonogestrel—Infection—Bleomycin—melanoma	0.00116	0.00267	CcSEcCtD
Etonogestrel—Nausea—Vemurafenib—melanoma	0.00115	0.00264	CcSEcCtD
Etonogestrel—Myalgia—Dactinomycin—melanoma	0.00114	0.00262	CcSEcCtD
Etonogestrel—Discomfort—Dactinomycin—melanoma	0.00113	0.00259	CcSEcCtD
Etonogestrel—Ill-defined disorder—Temozolomide—melanoma	0.00112	0.00258	CcSEcCtD
Etonogestrel—Anorexia—Bleomycin—melanoma	0.00112	0.00257	CcSEcCtD
Etonogestrel—Angioedema—Temozolomide—melanoma	0.00111	0.00254	CcSEcCtD
Etonogestrel—Oedema—Dactinomycin—melanoma	0.00109	0.00251	CcSEcCtD
Etonogestrel—Malaise—Temozolomide—melanoma	0.00109	0.00251	CcSEcCtD
Etonogestrel—Convulsion—Carmustine—melanoma	0.00109	0.00249	CcSEcCtD
Etonogestrel—Infection—Dactinomycin—melanoma	0.00109	0.00249	CcSEcCtD
Etonogestrel—Hypertension—Carmustine—melanoma	0.00108	0.00249	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Bleomycin—melanoma	0.00107	0.00245	CcSEcCtD
Etonogestrel—Myalgia—Carmustine—melanoma	0.00107	0.00245	CcSEcCtD
Etonogestrel—Anxiety—Carmustine—melanoma	0.00106	0.00244	CcSEcCtD
Etonogestrel—Cough—Temozolomide—melanoma	0.00106	0.00243	CcSEcCtD
Etonogestrel—Paraesthesia—Bleomycin—melanoma	0.00105	0.00242	CcSEcCtD
Etonogestrel—Weight increased—Docetaxel—melanoma	0.00105	0.00242	CcSEcCtD
Etonogestrel—Convulsion—Temozolomide—melanoma	0.00105	0.00241	CcSEcCtD
Etonogestrel—Weight decreased—Docetaxel—melanoma	0.00105	0.0024	CcSEcCtD
Etonogestrel—Hypertension—Temozolomide—melanoma	0.00105	0.0024	CcSEcCtD
Etonogestrel—Anorexia—Dactinomycin—melanoma	0.00104	0.00239	CcSEcCtD
Etonogestrel—Arthralgia—Temozolomide—melanoma	0.00103	0.00237	CcSEcCtD
Etonogestrel—Myalgia—Temozolomide—melanoma	0.00103	0.00237	CcSEcCtD
Etonogestrel—Infestation NOS—Docetaxel—melanoma	0.00103	0.00237	CcSEcCtD
Etonogestrel—Infestation—Docetaxel—melanoma	0.00103	0.00237	CcSEcCtD
Etonogestrel—Anxiety—Temozolomide—melanoma	0.00103	0.00236	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00102	0.00235	CcSEcCtD
Etonogestrel—Oedema—Carmustine—melanoma	0.00102	0.00235	CcSEcCtD
Etonogestrel—Discomfort—Temozolomide—melanoma	0.00102	0.00234	CcSEcCtD
Etonogestrel—Decreased appetite—Bleomycin—melanoma	0.00102	0.00234	CcSEcCtD
Etonogestrel—Infection—Carmustine—melanoma	0.00102	0.00233	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Docetaxel—melanoma	0.00101	0.00232	CcSEcCtD
Etonogestrel—Pain—Bleomycin—melanoma	0.001	0.0023	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000996	0.00229	CcSEcCtD
Etonogestrel—Oedema—Temozolomide—melanoma	0.000989	0.00227	CcSEcCtD
Etonogestrel—Anaphylactic shock—Temozolomide—melanoma	0.000989	0.00227	CcSEcCtD
Etonogestrel—Infection—Temozolomide—melanoma	0.000982	0.00226	CcSEcCtD
Etonogestrel—Anorexia—Carmustine—melanoma	0.000975	0.00224	CcSEcCtD
Etonogestrel—Nervous system disorder—Temozolomide—melanoma	0.00097	0.00223	CcSEcCtD
Etonogestrel—Feeling abnormal—Bleomycin—melanoma	0.000966	0.00222	CcSEcCtD
Etonogestrel—Skin disorder—Temozolomide—melanoma	0.00096	0.00221	CcSEcCtD
Etonogestrel—Decreased appetite—Dactinomycin—melanoma	0.00095	0.00218	CcSEcCtD
Etonogestrel—Fatigue—Dactinomycin—melanoma	0.000942	0.00216	CcSEcCtD
Etonogestrel—Anorexia—Temozolomide—melanoma	0.000942	0.00216	CcSEcCtD
Etonogestrel—Pain—Dactinomycin—melanoma	0.000935	0.00215	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Carmustine—melanoma	0.000932	0.00214	CcSEcCtD
Etonogestrel—Urticaria—Bleomycin—melanoma	0.000931	0.00214	CcSEcCtD
Etonogestrel—Haemoglobin—Docetaxel—melanoma	0.00093	0.00214	CcSEcCtD
Etonogestrel—Rhinitis—Docetaxel—melanoma	0.000928	0.00213	CcSEcCtD
Etonogestrel—Body temperature increased—Bleomycin—melanoma	0.000927	0.00213	CcSEcCtD
Etonogestrel—Haemorrhage—Docetaxel—melanoma	0.000925	0.00213	CcSEcCtD
Etonogestrel—Insomnia—Carmustine—melanoma	0.000925	0.00213	CcSEcCtD
Etonogestrel—Hypoaesthesia—Docetaxel—melanoma	0.000921	0.00211	CcSEcCtD
Etonogestrel—Paraesthesia—Carmustine—melanoma	0.000919	0.00211	CcSEcCtD
Etonogestrel—Pharyngitis—Docetaxel—melanoma	0.000919	0.00211	CcSEcCtD
Etonogestrel—Urinary tract disorder—Docetaxel—melanoma	0.000914	0.0021	CcSEcCtD
Etonogestrel—Somnolence—Carmustine—melanoma	0.00091	0.00209	CcSEcCtD
Etonogestrel—Connective tissue disorder—Docetaxel—melanoma	0.000909	0.00209	CcSEcCtD
Etonogestrel—Urethral disorder—Docetaxel—melanoma	0.000907	0.00208	CcSEcCtD
Etonogestrel—Feeling abnormal—Dactinomycin—melanoma	0.000901	0.00207	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Temozolomide—melanoma	0.000901	0.00207	CcSEcCtD
Etonogestrel—Insomnia—Temozolomide—melanoma	0.000894	0.00205	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dactinomycin—melanoma	0.000894	0.00205	CcSEcCtD
Etonogestrel—Visual impairment—Docetaxel—melanoma	0.000892	0.00205	CcSEcCtD
Etonogestrel—Decreased appetite—Carmustine—melanoma	0.000889	0.00204	CcSEcCtD
Etonogestrel—Paraesthesia—Temozolomide—melanoma	0.000888	0.00204	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Carmustine—melanoma	0.000883	0.00203	CcSEcCtD
Etonogestrel—Somnolence—Temozolomide—melanoma	0.000879	0.00202	CcSEcCtD
Etonogestrel—Pain—Carmustine—melanoma	0.000875	0.00201	CcSEcCtD
Etonogestrel—Constipation—Carmustine—melanoma	0.000875	0.00201	CcSEcCtD
Etonogestrel—Dyspepsia—Temozolomide—melanoma	0.00087	0.002	CcSEcCtD
Etonogestrel—Eye disorder—Docetaxel—melanoma	0.000865	0.00199	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—melanoma	0.000864	0.00198	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—melanoma	0.000864	0.00198	CcSEcCtD
Etonogestrel—Hypersensitivity—Bleomycin—melanoma	0.000864	0.00198	CcSEcCtD
Etonogestrel—Decreased appetite—Temozolomide—melanoma	0.000859	0.00197	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Temozolomide—melanoma	0.000854	0.00196	CcSEcCtD
Etonogestrel—Fatigue—Temozolomide—melanoma	0.000852	0.00196	CcSEcCtD
Etonogestrel—Pain—Temozolomide—melanoma	0.000845	0.00194	CcSEcCtD
Etonogestrel—Constipation—Temozolomide—melanoma	0.000845	0.00194	CcSEcCtD
Etonogestrel—Feeling abnormal—Carmustine—melanoma	0.000843	0.00194	CcSEcCtD
Etonogestrel—Asthenia—Bleomycin—melanoma	0.000841	0.00193	CcSEcCtD
Etonogestrel—Angiopathy—Docetaxel—melanoma	0.00084	0.00193	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Carmustine—melanoma	0.000837	0.00192	CcSEcCtD
Etonogestrel—Immune system disorder—Docetaxel—melanoma	0.000836	0.00192	CcSEcCtD
Etonogestrel—Pruritus—Bleomycin—melanoma	0.000829	0.0019	CcSEcCtD
Etonogestrel—Alopecia—Docetaxel—melanoma	0.000818	0.00188	CcSEcCtD
Etonogestrel—Feeling abnormal—Temozolomide—melanoma	0.000815	0.00187	CcSEcCtD
Etonogestrel—Mental disorder—Docetaxel—melanoma	0.000811	0.00186	CcSEcCtD
Etonogestrel—Body temperature increased—Carmustine—melanoma	0.000809	0.00186	CcSEcCtD
Etonogestrel—Abdominal pain—Carmustine—melanoma	0.000809	0.00186	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Temozolomide—melanoma	0.000808	0.00186	CcSEcCtD
Etonogestrel—Erythema—Docetaxel—melanoma	0.000806	0.00185	CcSEcCtD
Etonogestrel—Malnutrition—Docetaxel—melanoma	0.000806	0.00185	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—melanoma	0.000805	0.00185	CcSEcCtD
Etonogestrel—Urticaria—Temozolomide—melanoma	0.000785	0.0018	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—melanoma	0.000784	0.0018	CcSEcCtD
Etonogestrel—Body temperature increased—Temozolomide—melanoma	0.000782	0.00179	CcSEcCtD
Etonogestrel—Abdominal pain—Temozolomide—melanoma	0.000782	0.00179	CcSEcCtD
Etonogestrel—Back pain—Docetaxel—melanoma	0.000779	0.00179	CcSEcCtD
Etonogestrel—Muscle spasms—Docetaxel—melanoma	0.000775	0.00178	CcSEcCtD
Etonogestrel—Hypersensitivity—Carmustine—melanoma	0.000754	0.00173	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—melanoma	0.000748	0.00172	CcSEcCtD
Etonogestrel—Vomiting—Bleomycin—melanoma	0.000745	0.00171	CcSEcCtD
Etonogestrel—Rash—Bleomycin—melanoma	0.000739	0.0017	CcSEcCtD
Etonogestrel—Dermatitis—Bleomycin—melanoma	0.000738	0.0017	CcSEcCtD
Etonogestrel—Asthenia—Carmustine—melanoma	0.000734	0.00169	CcSEcCtD
Etonogestrel—Hypersensitivity—Temozolomide—melanoma	0.000728	0.00167	CcSEcCtD
Etonogestrel—Asthenia—Temozolomide—melanoma	0.000709	0.00163	CcSEcCtD
Etonogestrel—Cough—Docetaxel—melanoma	0.000703	0.00161	CcSEcCtD
Etonogestrel—Diarrhoea—Carmustine—melanoma	0.0007	0.00161	CcSEcCtD
Etonogestrel—Pruritus—Temozolomide—melanoma	0.0007	0.00161	CcSEcCtD
Etonogestrel—Convulsion—Docetaxel—melanoma	0.000698	0.0016	CcSEcCtD
Etonogestrel—Nausea—Bleomycin—melanoma	0.000696	0.0016	CcSEcCtD
Etonogestrel—Hypertension—Docetaxel—melanoma	0.000696	0.0016	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—melanoma	0.000695	0.0016	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—melanoma	0.000689	0.00158	CcSEcCtD
Etonogestrel—Myalgia—Docetaxel—melanoma	0.000686	0.00158	CcSEcCtD
Etonogestrel—Arthralgia—Docetaxel—melanoma	0.000686	0.00158	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000681	0.00156	CcSEcCtD
Etonogestrel—Dizziness—Carmustine—melanoma	0.000677	0.00155	CcSEcCtD
Etonogestrel—Diarrhoea—Temozolomide—melanoma	0.000676	0.00155	CcSEcCtD
Etonogestrel—Oedema—Docetaxel—melanoma	0.000658	0.00151	CcSEcCtD
Etonogestrel—Anaphylactic shock—Docetaxel—melanoma	0.000658	0.00151	CcSEcCtD
Etonogestrel—Dizziness—Temozolomide—melanoma	0.000654	0.0015	CcSEcCtD
Etonogestrel—Infection—Docetaxel—melanoma	0.000653	0.0015	CcSEcCtD
Etonogestrel—Vomiting—Carmustine—melanoma	0.000651	0.00149	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—melanoma	0.000649	0.00149	CcSEcCtD
Etonogestrel—Rash—Carmustine—melanoma	0.000645	0.00148	CcSEcCtD
Etonogestrel—Nervous system disorder—Docetaxel—melanoma	0.000645	0.00148	CcSEcCtD
Etonogestrel—Dermatitis—Carmustine—melanoma	0.000644	0.00148	CcSEcCtD
Etonogestrel—Headache—Carmustine—melanoma	0.000641	0.00147	CcSEcCtD
Etonogestrel—Skin disorder—Docetaxel—melanoma	0.000639	0.00147	CcSEcCtD
Etonogestrel—Vomiting—Temozolomide—melanoma	0.000629	0.00144	CcSEcCtD
Etonogestrel—Anorexia—Docetaxel—melanoma	0.000627	0.00144	CcSEcCtD
Etonogestrel—Rash—Temozolomide—melanoma	0.000623	0.00143	CcSEcCtD
Etonogestrel—Dermatitis—Temozolomide—melanoma	0.000623	0.00143	CcSEcCtD
Etonogestrel—Headache—Temozolomide—melanoma	0.000619	0.00142	CcSEcCtD
Etonogestrel—Nausea—Carmustine—melanoma	0.000608	0.0014	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Docetaxel—melanoma	0.000599	0.00138	CcSEcCtD
Etonogestrel—Insomnia—Docetaxel—melanoma	0.000595	0.00137	CcSEcCtD
Etonogestrel—Paraesthesia—Docetaxel—melanoma	0.00059	0.00136	CcSEcCtD
Etonogestrel—Nausea—Temozolomide—melanoma	0.000587	0.00135	CcSEcCtD
Etonogestrel—Somnolence—Docetaxel—melanoma	0.000585	0.00134	CcSEcCtD
Etonogestrel—Dyspepsia—Docetaxel—melanoma	0.000579	0.00133	CcSEcCtD
Etonogestrel—Decreased appetite—Docetaxel—melanoma	0.000572	0.00131	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Docetaxel—melanoma	0.000568	0.0013	CcSEcCtD
Etonogestrel—Fatigue—Docetaxel—melanoma	0.000567	0.0013	CcSEcCtD
Etonogestrel—Constipation—Docetaxel—melanoma	0.000562	0.00129	CcSEcCtD
Etonogestrel—Pain—Docetaxel—melanoma	0.000562	0.00129	CcSEcCtD
Etonogestrel—Feeling abnormal—Docetaxel—melanoma	0.000542	0.00124	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Docetaxel—melanoma	0.000538	0.00123	CcSEcCtD
Etonogestrel—Abdominal pain—Docetaxel—melanoma	0.00052	0.00119	CcSEcCtD
Etonogestrel—Body temperature increased—Docetaxel—melanoma	0.00052	0.00119	CcSEcCtD
Etonogestrel—Hypersensitivity—Docetaxel—melanoma	0.000484	0.00111	CcSEcCtD
Etonogestrel—Asthenia—Docetaxel—melanoma	0.000472	0.00108	CcSEcCtD
Etonogestrel—Pruritus—Docetaxel—melanoma	0.000465	0.00107	CcSEcCtD
Etonogestrel—Diarrhoea—Docetaxel—melanoma	0.00045	0.00103	CcSEcCtD
Etonogestrel—Dizziness—Docetaxel—melanoma	0.000435	0.000998	CcSEcCtD
Etonogestrel—Vomiting—Docetaxel—melanoma	0.000418	0.00096	CcSEcCtD
Etonogestrel—Rash—Docetaxel—melanoma	0.000415	0.000952	CcSEcCtD
Etonogestrel—Dermatitis—Docetaxel—melanoma	0.000414	0.000951	CcSEcCtD
Etonogestrel—Headache—Docetaxel—melanoma	0.000412	0.000946	CcSEcCtD
Etonogestrel—Nausea—Docetaxel—melanoma	0.000391	0.000897	CcSEcCtD
Etonogestrel—Testosterone—CYP1B1—melanoma	0.000375	0.269	CrCbGaD
Etonogestrel—Norethindrone—ALB—melanoma	0.000205	0.147	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ABCB1—melanoma	0.000203	0.146	CrCbGaD
Etonogestrel—Norethindrone—ABCB1—melanoma	0.000195	0.14	CrCbGaD
Etonogestrel—Methyltestosterone—ALB—melanoma	0.000194	0.14	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00016	0.000629	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL1—melanoma	0.00016	0.000628	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLCB4—melanoma	0.00016	0.000628	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000158	0.00062	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000158	0.00062	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK1—melanoma	0.000157	0.000617	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—melanoma	0.000157	0.000617	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR2—melanoma	0.000157	0.000615	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAC2—melanoma	0.000154	0.000605	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—WNT5A—melanoma	0.000152	0.000595	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFC—melanoma	0.000152	0.000595	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRRAP—melanoma	0.000151	0.00059	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CUL3—melanoma	0.000151	0.00059	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000149	0.000586	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—melanoma	0.000149	0.000583	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1B10—melanoma	0.000146	0.000574	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000146	0.000571	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.000145	0.00057	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000143	0.000562	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NPPA—melanoma	0.000141	0.000555	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CDKN2B—melanoma	0.000141	0.000552	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000138	0.00054	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—VDR—melanoma	0.000137	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—melanoma	0.000136	0.000535	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—F2RL1—melanoma	0.000136	0.000534	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000134	0.000525	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—F2R—melanoma	0.000133	0.000523	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000133	0.00052	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000131	0.000514	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000131	0.000514	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDNRB—melanoma	0.000129	0.000506	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRM3—melanoma	0.000128	0.000502	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PRKCA—melanoma	0.000127	0.000497	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—melanoma	0.000126	0.000495	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ERCC2—melanoma	0.000126	0.000492	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTK2B—melanoma	0.000125	0.000491	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000125	0.000489	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000124	0.000485	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH1—melanoma	0.000124	0.000485	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GAB2—melanoma	0.000122	0.000478	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNA11—melanoma	0.000122	0.000478	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KISS1—melanoma	0.000121	0.000476	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT1—melanoma	0.000121	0.000476	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—melanoma	0.000121	0.000474	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR1—melanoma	0.000118	0.000461	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SKI—melanoma	0.000118	0.000461	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—melanoma	0.000117	0.000458	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MC1R—melanoma	0.000116	0.000454	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR4—melanoma	0.000115	0.000449	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HDAC2—melanoma	0.000115	0.000449	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FOXO4—melanoma	0.000115	0.000449	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000114	0.000446	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—melanoma	0.000113	0.000445	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNAQ—melanoma	0.000113	0.000444	CbGpPWpGaD
Etonogestrel—Testosterone—ALB—melanoma	0.000113	0.0809	CrCbGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000112	0.00044	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—melanoma	0.000111	0.000437	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR7—melanoma	0.000111	0.000435	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRM1—melanoma	0.000111	0.000435	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00011	0.000431	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SUFU—melanoma	0.000108	0.000424	CbGpPWpGaD
Etonogestrel—Testosterone—ABCB1—melanoma	0.000108	0.0773	CrCbGaD
Etonogestrel—PGR—Signaling Pathways—SYK—melanoma	0.000107	0.000418	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ITGAV—melanoma	0.000105	0.00041	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NGFR—melanoma	0.000105	0.00041	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT3—melanoma	0.000105	0.00041	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HDAC2—melanoma	0.000103	0.000406	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH1—melanoma	0.000101	0.000398	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RHOB—melanoma	0.000101	0.000396	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BCL2L11—melanoma	0.000101	0.000396	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HDAC6—melanoma	9.7e-05	0.00038	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACER3—melanoma	9.69e-05	0.00038	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SOCS1—melanoma	9.68e-05	0.00038	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—S100B—melanoma	9.66e-05	0.000379	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—melanoma	9.57e-05	0.000375	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.29e-05	0.000364	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB4—melanoma	9.24e-05	0.000362	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR2—melanoma	9.2e-05	0.000361	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—melanoma	9.15e-05	0.000359	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAC2—melanoma	9.05e-05	0.000355	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—WNT5A—melanoma	8.91e-05	0.000349	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFC—melanoma	8.91e-05	0.000349	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UGT2B10—melanoma	8.86e-05	0.000347	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD86—melanoma	8.85e-05	0.000347	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—melanoma	8.78e-05	0.000345	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CSF2—melanoma	8.59e-05	0.000337	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF1—melanoma	8.59e-05	0.000337	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—E2F1—melanoma	8.4e-05	0.00033	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRA—melanoma	8.32e-05	0.000326	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—melanoma	8.26e-05	0.000324	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HS3ST5—melanoma	8.24e-05	0.000323	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRKCA—melanoma	8.23e-05	0.000323	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ITGB3—melanoma	8.23e-05	0.000323	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—melanoma	8.07e-05	0.000317	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—VDR—melanoma	8.06e-05	0.000316	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAP2K2—melanoma	8.05e-05	0.000316	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—F2R—melanoma	7.82e-05	0.000307	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—melanoma	7.65e-05	0.0003	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAC1—melanoma	7.63e-05	0.000299	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDNRB—melanoma	7.57e-05	0.000297	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PRKCA—melanoma	7.43e-05	0.000291	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ERCC2—melanoma	7.37e-05	0.000289	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTK2B—melanoma	7.35e-05	0.000288	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—melanoma	7.32e-05	0.000287	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNA11—melanoma	7.15e-05	0.000281	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GAB2—melanoma	7.15e-05	0.000281	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT1—melanoma	7.12e-05	0.000279	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—melanoma	7e-05	0.000275	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FN1—melanoma	6.74e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR4—melanoma	6.72e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HDAC2—melanoma	6.72e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FOXO4—melanoma	6.72e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—melanoma	6.65e-05	0.000261	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNAQ—melanoma	6.65e-05	0.000261	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—melanoma	6.59e-05	0.000259	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD80—melanoma	6.46e-05	0.000253	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—melanoma	6.45e-05	0.000253	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—melanoma	6.45e-05	0.000253	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—melanoma	6.45e-05	0.000253	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGF—melanoma	6.37e-05	0.00025	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SYK—melanoma	6.25e-05	0.000245	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLCB4—melanoma	6.24e-05	0.000245	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ITGAV—melanoma	6.14e-05	0.000241	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT3—melanoma	6.14e-05	0.000241	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NGFR—melanoma	6.14e-05	0.000241	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—melanoma	6.06e-05	0.000238	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—melanoma	5.95e-05	0.000233	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—melanoma	5.9e-05	0.000232	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC6A11—melanoma	5.87e-05	0.00023	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIP4K2A—melanoma	5.87e-05	0.00023	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTAP—melanoma	5.71e-05	0.000224	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAP2K1—melanoma	5.71e-05	0.000224	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SOCS1—melanoma	5.68e-05	0.000223	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—melanoma	5.67e-05	0.000222	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—S100B—melanoma	5.67e-05	0.000222	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—melanoma	5.62e-05	0.00022	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—melanoma	5.61e-05	0.00022	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—melanoma	5.46e-05	0.000214	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF2—melanoma	5.43e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB4—melanoma	5.42e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—melanoma	5.37e-05	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD86—melanoma	5.2e-05	0.000204	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—melanoma	5.16e-05	0.000202	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LUM—melanoma	5.09e-05	0.0002	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PHGDH—melanoma	5.09e-05	0.0002	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDM2—melanoma	5.08e-05	0.000199	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CSF2—melanoma	5.04e-05	0.000198	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF1—melanoma	5.04e-05	0.000198	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—melanoma	5.01e-05	0.000196	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HPSE—melanoma	4.99e-05	0.000196	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—melanoma	4.94e-05	0.000194	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—E2F1—melanoma	4.93e-05	0.000193	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CUBN—melanoma	4.9e-05	0.000192	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRA—melanoma	4.88e-05	0.000191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ITGB3—melanoma	4.83e-05	0.000189	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCA—melanoma	4.83e-05	0.000189	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—melanoma	4.75e-05	0.000186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—melanoma	4.74e-05	0.000186	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SDHD—melanoma	4.73e-05	0.000186	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BSG—melanoma	4.73e-05	0.000186	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CSPG4—melanoma	4.73e-05	0.000186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAP2K2—melanoma	4.72e-05	0.000185	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—melanoma	4.64e-05	0.000182	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPAM—melanoma	4.58e-05	0.00018	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—melanoma	4.54e-05	0.000178	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—melanoma	4.54e-05	0.000178	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—melanoma	4.49e-05	0.000176	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAC1—melanoma	4.48e-05	0.000176	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—melanoma	4.42e-05	0.000173	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—melanoma	4.38e-05	0.000172	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—melanoma	4.3e-05	0.000168	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—melanoma	4.29e-05	0.000168	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—melanoma	4.28e-05	0.000168	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—melanoma	4.27e-05	0.000167	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFKB1—melanoma	4.25e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—melanoma	4.11e-05	0.000161	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FN1—melanoma	3.95e-05	0.000155	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLA2G6—melanoma	3.9e-05	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—melanoma	3.87e-05	0.000152	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—melanoma	3.86e-05	0.000151	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—melanoma	3.82e-05	0.00015	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—melanoma	3.81e-05	0.000149	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD80—melanoma	3.79e-05	0.000149	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—melanoma	3.78e-05	0.000148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—melanoma	3.78e-05	0.000148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—melanoma	3.78e-05	0.000148	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—melanoma	3.78e-05	0.000148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGF—melanoma	3.74e-05	0.000147	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—melanoma	3.65e-05	0.000143	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—melanoma	3.56e-05	0.00014	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—melanoma	3.55e-05	0.000139	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—VCAN—melanoma	3.5e-05	0.000137	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK1—melanoma	3.47e-05	0.000136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—melanoma	3.47e-05	0.000136	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—melanoma	3.46e-05	0.000136	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAP2K1—melanoma	3.35e-05	0.000131	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—melanoma	3.33e-05	0.00013	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—melanoma	3.29e-05	0.000129	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—melanoma	3.28e-05	0.000129	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—melanoma	3.2e-05	0.000126	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF2—melanoma	3.19e-05	0.000125	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—melanoma	3.01e-05	0.000118	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDM2—melanoma	2.98e-05	0.000117	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP17A1—melanoma	2.95e-05	0.000116	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—melanoma	2.94e-05	0.000115	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—melanoma	2.91e-05	0.000114	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—melanoma	2.9e-05	0.000114	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNA11—melanoma	2.79e-05	0.000109	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—melanoma	2.79e-05	0.000109	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—melanoma	2.79e-05	0.000109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FASN—melanoma	2.73e-05	0.000107	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—melanoma	2.72e-05	0.000107	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A5—melanoma	2.68e-05	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—melanoma	2.67e-05	0.000105	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—melanoma	2.67e-05	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—melanoma	2.66e-05	0.000104	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—melanoma	2.6e-05	0.000102	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNAQ—melanoma	2.59e-05	0.000102	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CD44—melanoma	2.59e-05	0.000102	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—melanoma	2.57e-05	0.000101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—melanoma	2.52e-05	9.88e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—melanoma	2.51e-05	9.85e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—melanoma	2.51e-05	9.83e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFKB1—melanoma	2.49e-05	9.78e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1B1—melanoma	2.49e-05	9.75e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—melanoma	2.46e-05	9.65e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—melanoma	2.26e-05	8.88e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—melanoma	2.24e-05	8.79e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—melanoma	2.24e-05	8.77e-05	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—melanoma	2.22e-05	8.71e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—melanoma	2.14e-05	8.4e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—melanoma	2.08e-05	8.17e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—melanoma	2.05e-05	8.03e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK1—melanoma	2.04e-05	7.99e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—melanoma	2.04e-05	7.99e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—melanoma	1.92e-05	7.55e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PRKCA—melanoma	1.88e-05	7.39e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ERCC2—melanoma	1.87e-05	7.33e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—melanoma	1.77e-05	6.93e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—melanoma	1.71e-05	6.71e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—melanoma	1.64e-05	6.41e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—melanoma	1.57e-05	6.14e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—melanoma	1.48e-05	5.79e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—melanoma	1.44e-05	5.66e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—melanoma	1.42e-05	5.58e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—melanoma	1.3e-05	5.09e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—melanoma	1.28e-05	5.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—melanoma	1.13e-05	4.43e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—melanoma	1.12e-05	4.39e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—melanoma	9.77e-06	3.83e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—melanoma	6.89e-06	2.7e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—melanoma	5.63e-06	2.21e-05	CbGpPWpGaD
